20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Fmoc-His(Boc)-OH·CHA vs. Other Histidine Derivatives in SPPS

In the field of peptide synthesis, the incorporation of histidine is often a focal point for researchers due to its unique chemical properties and its prevalence in biologically active peptides. However, the inherent susceptibility of histidine to epimerization during solid-phase peptide synthesis (SPPS) necessitates the use of carefully designed protecting groups. This article compares Fmoc-His(Boc)-OH·CHA with other histidine protection strategies, highlighting why it is a preferred choice for minimizing epimerization and maximizing peptide purity, especially for manufacturers and scientists seeking reliable synthesis results.

Historically, various protecting groups have been employed for histidine in SPPS. Early strategies often utilized trityl (Trt) or dinitrophenyl (Dnp) groups for the imidazole nitrogen. While these groups offered some protection, they often presented challenges. Trityl, for instance, can be labile under certain conditions and may lead to side reactions or incomplete deprotection. Dnp protection, while more robust, requires harsher conditions for removal, potentially impacting other sensitive functional groups within the peptide chain.

The advent of Fmoc-based SPPS revolutionized peptide synthesis, favoring milder, base-labile protecting groups. For histidine, the combination of Fmoc for the alpha-amino group and Boc for the imidazole nitrogen, as seen in Fmoc-His(Boc)-OH·CHA, offers a significant advantage. The Boc group is stable to the piperidine used for Fmoc removal but is readily cleaved under mild acidic conditions, typically trifluoroacetic acid (TFA), which is also used for final peptide cleavage from the resin. This orthogonality ensures that the imidazole protection remains intact until the final deprotection step, preventing epimerization during repeated Fmoc deprotection and coupling cycles.

Compared to other Fmoc-compatible histidine derivatives, such as those protected with tosyl (Tos) or trimethylsulfonylethyl (Mse) groups, the Boc protection offers a balanced profile. Tosyl protection, while effective, can sometimes lead to difficult deprotection or side reactions. Mse protection is known for its orthogonality but can be more complex to implement. Fmoc-His(Boc)-OH·CHA, on the other hand, provides a straightforward and highly effective solution for minimizing epimerization. The stability of the Boc group under Fmoc deprotection conditions and its facile removal during final cleavage make it an ideal choice for researchers and manufacturers aiming for high-purity peptide synthesis. When you purchase Fmoc-His(Boc)-OH·CHA, you are opting for a well-established and proven methodology.

The cyclohexylamine (CHA) salt form of Fmoc-His(Boc)-OH·CHA further enhances its utility. It often provides better crystallinity and handling properties compared to the free acid or other salt forms, making it easier for procurement managers to source and for chemists to use in their synthesis protocols. For those looking to buy this essential reagent, understanding these comparative advantages helps in selecting the most effective histidine building block for their SPPS needs. It’s advisable to connect with suppliers who can provide comprehensive technical data supporting these benefits.

In conclusion, while various histidine protection strategies exist, Fmoc-His(Boc)-OH·CHA stands out as a superior option for Fmoc-based SPPS. Its effective dual protection minimizes epimerization, enhances peptide purity, and offers good compatibility with standard SPPS protocols. For researchers and procurement specialists seeking the best building blocks, choosing this derivative is a strategic decision for achieving high-quality peptide synthesis. If you are looking to buy Fmoc-His(Boc)-OH·CHA, consider contacting our sales team for a competitive quote and detailed product information.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Sourcing Fmoc-His(Boc)-OH·CHA: A Buyer's Guide to Quality Peptide Building Blocks

Next: The Role of Fmoc-His(Boc)-OH·CHA in Pharmaceutical Peptide Manufacturing

All Rights Reserved